The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design
FA Rey, K Stiasny, MC Vaney, M Dellarole… - EMBO reports, 2018 - embopress.org
Zika and dengue viruses belong to the Flavivirus genus, a close group of antigenically
related viruses that cause significant arthropod‐transmitted diseases throughout the globe …
related viruses that cause significant arthropod‐transmitted diseases throughout the globe …
Current development and challenges of tetravalent live-attenuated dengue vaccines
Dengue is the most common arboviral disease caused by one of four distinct but closely
related dengue viruses (DENV) and places significant economic and public health burdens …
related dengue viruses (DENV) and places significant economic and public health burdens …
Magnitude of antibody cross-reactivity in medically important mosquito-borne flaviviruses: a systematic review
A Endale, G Medhin, K Darfiro, N Kebede… - Infection and drug …, 2021 - Taylor & Francis
Introduction Flaviviruses are a genus of enveloped single-stranded RNA viruses that include
dengue virus (DENV), yellow fever virus, West Nile virus (WNV), Japanese encephalitis …
dengue virus (DENV), yellow fever virus, West Nile virus (WNV), Japanese encephalitis …
Homotypic dengue virus reinfections in Nicaraguan children
JJ Waggoner, A Balmaseda, L Gresh… - The Journal of …, 2016 - academic.oup.com
Background. Infection with any of the 4 related dengue virus serotypes (DENV-1–4) is
thought to result in lifelong immunity to homotypic reinfection (ie, reinfection with the same …
thought to result in lifelong immunity to homotypic reinfection (ie, reinfection with the same …
The complexity of a dengue vaccine: a review of the human antibody response
Dengue is the most prevalent mosquito-borne viral disease worldwide. Yet, there are no
vaccines or specific antivirals available to prevent or treat the disease. Several dengue …
vaccines or specific antivirals available to prevent or treat the disease. Several dengue …
[HTML][HTML] Safety and immunogenicity of a tetravalent dengue DNA vaccine administered with a cationic lipid-based adjuvant in a phase 1 clinical trial
JR Danko, T Kochel, N Teneza-Mora… - The American journal …, 2018 - ncbi.nlm.nih.gov
We conducted an open label, dose escalation Phase 1 clinical trial of a tetravalent dengue
DNA vaccine (TVDV) formulated in Vaxfectin® to assess safety and immunogenicity. A total …
DNA vaccine (TVDV) formulated in Vaxfectin® to assess safety and immunogenicity. A total …
Vertebrate reservoirs of arboviruses: Myth, synonym of amplifier, or reality?
The rapid succession of the pandemic of arbovirus diseases, such as dengue, West Nile
fever, chikungunya, and Zika fever, has intensified research on these and other arbovirus …
fever, chikungunya, and Zika fever, has intensified research on these and other arbovirus …
Dengue virus neutralizing antibody levels associated with protection from infection in thai cluster studies
D Buddhari, J Aldstadt, TP Endy… - PLoS neglected …, 2014 - journals.plos.org
Background Long-term homologous and temporary heterologous protection from dengue
virus (DENV) infection may be mediated by neutralizing antibodies. However, neutralizing …
virus (DENV) infection may be mediated by neutralizing antibodies. However, neutralizing …
[HTML][HTML] Serodiagnosis of asymptomatic dengue infection
S Chatchen, A Sabchareon, C Sirivichayakul - Asian Pacific journal of …, 2017 - Elsevier
Dengue virus (DENV) is a mosquito-transmitted virus that is expanding across the world.
The incidence of dengue infection, especially severe disease, has been increasing. DENV …
The incidence of dengue infection, especially severe disease, has been increasing. DENV …
[HTML][HTML] Next generation dengue vaccines: a review of the preclinical development pipeline
KS Vannice, JT Roehrig, J Hombach - Vaccine, 2015 - Elsevier
Dengue represents a significant and growing public health problem across the globe, with
approximately half of the world's population at risk. The increasing and expanding burden of …
approximately half of the world's population at risk. The increasing and expanding burden of …